Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice. [electronic resource]
Producer: 20120118Description: 399-410 p. digitalISSN:- 1873-7544
- Analysis of Variance
- Animals
- Animals, Newborn
- Brain-Derived Neurotrophic Factor -- pharmacology
- Bromodeoxyuridine -- metabolism
- Cells, Cultured
- Cyclic Nucleotide Phosphodiesterases, Type 5 -- metabolism
- Diabetes Complications -- physiopathology
- Diabetic Neuropathies -- drug therapy
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Gene Expression Regulation -- drug effects
- Hyperalgesia -- drug therapy
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Neurologic Mutants
- Nerve Tissue Proteins -- metabolism
- Neural Conduction -- drug effects
- Pain Measurement -- methods
- Pain Threshold -- drug effects
- Phosphodiesterase 5 Inhibitors -- therapeutic use
- Piperazines -- therapeutic use
- Purines -- therapeutic use
- RNA, Small Interfering -- genetics
- Receptors, Leptin -- deficiency
- Schwann Cells -- drug effects
- Sciatic Neuropathy -- drug therapy
- Sildenafil Citrate
- Sulfones -- therapeutic use
- Time Factors
- Transfection -- methods
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.